Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia
Abstract Objective Friedreich ataxia (FRDA) is an inherited condition caused by a GAA triplet repeat (GAA‐TR) expansion in the FXN gene. Clinical features of FRDA include ataxia, cardiomyopathy, and in some, vision loss. In this study, we characterize features of vision loss in a large cohort of adults and children with FRDA. Methods Using optical coherence tomography (OCT), we measured peripapillary retinal nerve fiber layer (RNFL) thickness in 198 people with FRDA, and 77 controls. Sloan letter charts were used to determine visual acuity. RNFL thickness and visual acuity were compared to measures of disease severity obtained from the Friedreich Ataxia Clinical Outcomes Measures Study (FACOMS). Results The majority of patients, including children, had pathologically thin RNFLs (mean = 73 ± 13 μm in FRDA; 98 ± 9 μm in controls) and low‐contrast vision deficits early in the disease course. Variability in RNFL thickness in FRDA (range: 36 to 107 μm) was best predicted by disease burden (GAA‐TR length X disease duration). Significant deficits in high‐contrast visual acuity were apparent in patients with an RNFL thickness of ≤68 μm. RNFL thickness decreased at a rate of −1.2 ± 1.4 μm/year and reached 68 μm at a disease burden of approximately 12,000 GAA years, equivalent to disease duration of 17 years for participants with 700 GAAs. Interpretation These data suggest that both hypoplasia and subsequent degeneration of the RNFL may be responsible for the optic nerve dysfunction in FRDA and support the development of a vision‐directed treatment for selected patients early in the disease to prevent RNFL loss from reaching the critical threshold..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Annals of Clinical and Translational Neurology - 10(2023), 8, Seite 1397-1406 |
| Beteiligte Personen: |
Rodden, Layne N. [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 American Neurological Association |
|---|
| Umfang: |
1406 |
|---|
| doi: |
10.1002/acn3.51830 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY014764032 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY014764032 | ||
| 003 | DE-627 | ||
| 005 | 20231111114625.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/acn3.51830 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_ACN3_2023_10_8.zip.xml |
| 035 | |a (DE-627)WLY014764032 | ||
| 035 | |a (WILEY)ACN351830 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Rodden, Layne N. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia |
| 264 | 1 | |c 2023 | |
| 300 | |a 1406 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 American Neurological Association | ||
| 520 | |a Abstract Objective Friedreich ataxia (FRDA) is an inherited condition caused by a GAA triplet repeat (GAA‐TR) expansion in the FXN gene. Clinical features of FRDA include ataxia, cardiomyopathy, and in some, vision loss. In this study, we characterize features of vision loss in a large cohort of adults and children with FRDA. Methods Using optical coherence tomography (OCT), we measured peripapillary retinal nerve fiber layer (RNFL) thickness in 198 people with FRDA, and 77 controls. Sloan letter charts were used to determine visual acuity. RNFL thickness and visual acuity were compared to measures of disease severity obtained from the Friedreich Ataxia Clinical Outcomes Measures Study (FACOMS). Results The majority of patients, including children, had pathologically thin RNFLs (mean = 73 ± 13 μm in FRDA; 98 ± 9 μm in controls) and low‐contrast vision deficits early in the disease course. Variability in RNFL thickness in FRDA (range: 36 to 107 μm) was best predicted by disease burden (GAA‐TR length X disease duration). Significant deficits in high‐contrast visual acuity were apparent in patients with an RNFL thickness of ≤68 μm. RNFL thickness decreased at a rate of −1.2 ± 1.4 μm/year and reached 68 μm at a disease burden of approximately 12,000 GAA years, equivalent to disease duration of 17 years for participants with 700 GAAs. Interpretation These data suggest that both hypoplasia and subsequent degeneration of the RNFL may be responsible for the optic nerve dysfunction in FRDA and support the development of a vision‐directed treatment for selected patients early in the disease to prevent RNFL loss from reaching the critical threshold. | ||
| 700 | 1 | |a McIntyre, Kellie |4 aut | |
| 700 | 1 | |a Keita, Medina |4 aut | |
| 700 | 1 | |a Wells, Mckenzie |4 aut | |
| 700 | 1 | |a Park, Courtney |4 aut | |
| 700 | 1 | |a Profeta, Victoria |4 aut | |
| 700 | 1 | |a Waldman, Amy |4 aut | |
| 700 | 1 | |a Rummey, Christian |4 aut | |
| 700 | 1 | |a Balcer, Laura J. |4 aut | |
| 700 | 1 | |a Lynch, David R. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of Clinical and Translational Neurology |g 10(2023), 8, Seite 1397-1406 |w (DE-627)WLY000068497 |x 23289503 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2023 |g number:8 |g pages:1397-1406 |g extent:1406 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2023 |e 8 |h 1397-1406 |g 1406 | ||